ALDH5A1 and neoplasm: Overall, our study shows for the first time that miR-210 mediated targeting of the mitochondrial ALDH5A1 reprograms the metabolism of GBM cells and also uncovers the tumor suppressive role of ALDH5A1 in GBM (Fig. 8).